For: | Favresse J, Gruson D, Gheldof D. Comment on "High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders". Mol Genet Metab Rep 2019;21:100506. [PMID: 31467852 DOI: 10.1016/j.ymgmr.2019.100506] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Wauthier L, Plebani M, Favresse J. Interferences in immunoassays: review and practical algorithm. Clin Chem Lab Med 2022. [PMID: 35304841 DOI: 10.1515/cclm-2021-1288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis] |
2 | Favresse J, Bayart J, Stoefs A, Gheldof D, Douxfils J, Dogné J, Gruson D. Neutralization of biotin interference: preliminary evaluation of the VeraTest Biotin™, VeraPrep Biotin™ and BioT-Filter ®. Clinical Chemistry and Laboratory Medicine (CCLM) 2020;58:e130-3. [DOI: 10.1515/cclm-2019-1121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis] |
3 | Wolf B. Response to comment on "High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders". Mol Genet Metab Rep 2019;21:100511. [PMID: 31516832 DOI: 10.1016/j.ymgmr.2019.100511] [Reference Citation Analysis] |